Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharyngeal and cutaneous diphtheria: a tail of a refugee.
Galfo V, Riccardi N, Leonildi A, Falcone M, Barnini S. Galfo V, et al. Among authors: riccardi n. Infection. 2023 Oct;51(5):1599-1600. doi: 10.1007/s15010-023-01990-4. Epub 2023 Jan 31. Infection. 2023. PMID: 36719633 No abstract available.
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience.
Tiseo G, Barbieri C, Galfo V, Occhineri S, Matucci T, Almerigogna F, Kalo J, Sponga P, Cesaretti M, Marchetti G, Forniti A, Caroselli C, Ferranti S, Pogliaghi M, Polidori M, Fabiani S, Verdenelli S, Tagliaferri E, Riccardi N, Suardi LR, Carmignani C, Batini S, Puccetti L, Iapoce R, Menichetti F, Falcone M. Tiseo G, et al. Among authors: riccardi n. Infect Dis Ther. 2023 Jan;12(1):257-271. doi: 10.1007/s40121-022-00729-2. Epub 2022 Nov 28. Infect Dis Ther. 2023. PMID: 36441485 Free PMC article.
Real-world experience with meropenem/vaborbactam for the treatment of infections caused by ESBL-producing Enterobacterales and carbapenem-resistant Klebsiella pneumoniae.
Tiseo G, Galfo V, Riccardi N, Suardi LR, Pogliaghi M, Giordano C, Leonildi A, Barnini S, Falcone M. Tiseo G, et al. Among authors: riccardi n. Eur J Clin Microbiol Infect Dis. 2024 Feb 20. doi: 10.1007/s10096-024-04758-2. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38376634
Chemotherapy Mass Campaigns and Migratory Flows: An Unexpected Connection.
Cenderello G, Taramasso L, Riccardi N, Di Biagio A, Cassola G, De Maria A. Cenderello G, et al. Among authors: riccardi n. Clin Infect Dis. 2016 May 15;62(10):1323. doi: 10.1093/cid/ciw087. Epub 2016 Feb 16. Clin Infect Dis. 2016. PMID: 26908811 Free article. No abstract available.
Onychomadesis in a male patient with secondary syphilis.
Di Biagio A, Taramasso L, Gustinetti G, Riccardi N, Viscoli C. Di Biagio A, et al. Among authors: riccardi n. Int J STD AIDS. 2016 Jul;27(8):704-5. doi: 10.1177/0956462416628703. Int J STD AIDS. 2016. PMID: 27278451 Free article. No abstract available.
Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides.
Di Biagio A, Riccardi N, Taramasso L, Capetti A, Cenderello G, Signori A, Vitiello P, Guerra M, de Socio GV, Cassola G, Quirino T, Viscoli C. Di Biagio A, et al. Among authors: riccardi n. Int J Antimicrob Agents. 2016 Nov;48(5):551-554. doi: 10.1016/j.ijantimicag.2016.07.009. Epub 2016 Aug 17. Int J Antimicrob Agents. 2016. PMID: 27566908
175 results